Clinical aspects of the use of ribociclib

Clinical aspects of the use of ribociclib

Luminal metastatic HER2-negative breast cancer remains one of the most common cancers in oncological practice. This disease still remains incurable. Endocrine therapy remained the standard therapy of choice for disseminated patients for a long time. The search for new effective drugs, development of...

Full description

Bibliographic Details
Main Authors: A. A. Markovich, M. V. Kalugin, O. О. Gordeeva, M. Zh. Yakoobova
Format: Article
Language:Russian
Published: Remedium Group LLC 2020-07-01
Series:Медицинский совет
Subjects:
breast cancer
endocrine therapy
endocrine resistance
visceral crisis
cdk4/6
ribociclib
survival
quality of life
toxicity
neutropenia
g-csf
hepatic toxicity
dexamethasone
Online Access:https://www.med-sovet.pro/jour/article/view/5700

Internet

https://www.med-sovet.pro/jour/article/view/5700

Similar Items